No Detail Found!

Comparative study between Olanzapine, an atypical antipsychotic and conventional agent, Haloperidol used to treat Schizophrenia.

Author(s)
Asiya Atif Liaquat College of Medicine and Dentistry, Karachi, Pakistan
Najmus Sahar Syed Liaquat College of Medicine and Dentistry, Karachi, Pakistan
Muhammad Jawed Liaquat College of Medicine and Dentistry, Karachi, Pakistan
Muhammad Rafique Gheewala Dow University of Health Sciences & Civil Hospital, Karachi, Pakistan
Abstract
An observational and comparative study was conducted to compare the functional outcome between the patients treated with conventional antipsychotic agent Haloperidol and atypical antipsychotic agent Olanzapine (zyprexa). A total of 32 patients were included in the study with established schizophrenia according to (DSM IV). The data was processed on SSPE 10th version. The primary outcome measure was the improvement of negative symptoms of schizophrenia and secondary outcome measure was to observe the superiority of the atypical drug Olanzapine over conventional agent Haloperidol regarding side effects. Patients were assessed at baseline, 2nd and 8th week, using four tools of assessment. For treatment group receiving Haloperidol mean was 47.2 at 8th week with SD of ±11.50 and for Olanzapine treatment group mean were 36.5 with SD of ±18.90. The P values for all the parameters in the Olanzapine group were significant as compared to Haloperidol.
Publication Details
Page(s) 110-114
DOI DOI not available
Published Journal: Pakistan Journal of Biochemistry and Molecular Biology , Volume: 40, Issue: 2, Year: 2007

Request the full text from PASTIC

0

Citations

0

Downloads

46

Views